Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro
Fei Qin,1,* Yun Ma,1,* Xiao Li,2 Xian Wang,1 Yuanyi Wei,1 Chuqi Hou,3 Si Lin,1 Lianbing Hou,1 Chengxi Wang4 1Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, 2Department of Pharmacy, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, 3Department of Ph...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/b03221c40c4245718fe22abb0898e6b2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:b03221c40c4245718fe22abb0898e6b2 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:b03221c40c4245718fe22abb0898e6b22021-12-02T00:39:20ZEfficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro1178-2013https://doaj.org/article/b03221c40c4245718fe22abb0898e6b22015-05-01T00:00:00Zhttp://www.dovepress.com/efficacy-and-mechanism-of-tanshinone-iia-liquid-nanoparticles-in-preve-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Fei Qin,1,* Yun Ma,1,* Xiao Li,2 Xian Wang,1 Yuanyi Wei,1 Chuqi Hou,3 Si Lin,1 Lianbing Hou,1 Chengxi Wang4 1Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, 2Department of Pharmacy, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, 3Department of Pharmacology, Southern Medical University, 4Department of Pharmacology, Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China *These authors contributed equally to this work Abstract: Up to 90% of patients develop adhesion following laparotomy. Upregulating fibrinolysis within the peritoneum reduces adhesions. Tanshinone IIA (Tan IIA) promotes fibrinolysis in hepatic fibrosis and the cardiovascular system and may play a role in preventing adhesions. We report preparation and characterization of liquid nanoparticles of Tan IIA for intravenous administration and investigate its feasibility in clinical practice. Tan IIA liquid nanoparticles (Tan IIA-NPs) were prepared using the emulsion/solvent evaporation method. Adhesions were induced in Sprague–Dawley rats by injuring the parietal peritoneum and cecum, followed by intravenous administration of various Tan IIA-NP dosages. The adhesion scores for each group were collected 7 days after the initial laparotomy. The activity of tissue-type plasminogen activator (tPA) was measured from the peritoneal lavage fluid. The messenger RNA and protein expression levels of plasminogen activator inhibitor-1 (PAI-1) were measured by quantitative real-time polymerase chain reaction and enzyme-linked immunosorbent assay. TGF-β1 and collagen I expressions were measured immunohistochemically in the ischemic tissues. The effects of Tan IIA-NPs and free-Tan IIA on tPA and PAI-1 were measured in vitro in TGF-β1-induced HMrSV5 cells. Tan IIA-NPs exhibited small particle size, high encapsulation efficiency, good stability for storage, and safety for intravenous administration. Tan IIA-NPs were effective in preventing adhesion. Tan IIA-NPs increased tPA activity in peritoneal lavage fluid, and tPA mRNA and protein expression, and decreased PAI-1 mRNA and protein expression in the ischemic tissues. Moreover, Tan IIA-NPs decreased TGF-β1 and collagen I expressions in the ischemic tissues. Tan IIA-NPs administered via tail veins upregulated fibrinolysis in the peritoneum. In vitro studies showed that these effects may be mediated by the TGF-β signal pathway. Keywords: peritoneal fibrinolysis, tissue-type plasminogen activator, plasminogen activator inhibitor-1Qin FMa YLi XWang XWei YHou CLin SHou LWang CDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2015, Iss default, Pp 3699-3717 (2015) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Qin F Ma Y Li X Wang X Wei Y Hou C Lin S Hou L Wang C Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro |
| description |
Fei Qin,1,* Yun Ma,1,* Xiao Li,2 Xian Wang,1 Yuanyi Wei,1 Chuqi Hou,3 Si Lin,1 Lianbing Hou,1 Chengxi Wang4 1Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, 2Department of Pharmacy, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, 3Department of Pharmacology, Southern Medical University, 4Department of Pharmacology, Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China *These authors contributed equally to this work Abstract: Up to 90% of patients develop adhesion following laparotomy. Upregulating fibrinolysis within the peritoneum reduces adhesions. Tanshinone IIA (Tan IIA) promotes fibrinolysis in hepatic fibrosis and the cardiovascular system and may play a role in preventing adhesions. We report preparation and characterization of liquid nanoparticles of Tan IIA for intravenous administration and investigate its feasibility in clinical practice. Tan IIA liquid nanoparticles (Tan IIA-NPs) were prepared using the emulsion/solvent evaporation method. Adhesions were induced in Sprague–Dawley rats by injuring the parietal peritoneum and cecum, followed by intravenous administration of various Tan IIA-NP dosages. The adhesion scores for each group were collected 7 days after the initial laparotomy. The activity of tissue-type plasminogen activator (tPA) was measured from the peritoneal lavage fluid. The messenger RNA and protein expression levels of plasminogen activator inhibitor-1 (PAI-1) were measured by quantitative real-time polymerase chain reaction and enzyme-linked immunosorbent assay. TGF-β1 and collagen I expressions were measured immunohistochemically in the ischemic tissues. The effects of Tan IIA-NPs and free-Tan IIA on tPA and PAI-1 were measured in vitro in TGF-β1-induced HMrSV5 cells. Tan IIA-NPs exhibited small particle size, high encapsulation efficiency, good stability for storage, and safety for intravenous administration. Tan IIA-NPs were effective in preventing adhesion. Tan IIA-NPs increased tPA activity in peritoneal lavage fluid, and tPA mRNA and protein expression, and decreased PAI-1 mRNA and protein expression in the ischemic tissues. Moreover, Tan IIA-NPs decreased TGF-β1 and collagen I expressions in the ischemic tissues. Tan IIA-NPs administered via tail veins upregulated fibrinolysis in the peritoneum. In vitro studies showed that these effects may be mediated by the TGF-β signal pathway. Keywords: peritoneal fibrinolysis, tissue-type plasminogen activator, plasminogen activator inhibitor-1 |
| format |
article |
| author |
Qin F Ma Y Li X Wang X Wei Y Hou C Lin S Hou L Wang C |
| author_facet |
Qin F Ma Y Li X Wang X Wei Y Hou C Lin S Hou L Wang C |
| author_sort |
Qin F |
| title |
Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro |
| title_short |
Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro |
| title_full |
Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro |
| title_fullStr |
Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro |
| title_full_unstemmed |
Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro |
| title_sort |
efficacy and mechanism of tanshinone iia liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro |
| publisher |
Dove Medical Press |
| publishDate |
2015 |
| url |
https://doaj.org/article/b03221c40c4245718fe22abb0898e6b2 |
| work_keys_str_mv |
AT qinf efficacyandmechanismoftanshinoneiialiquidnanoparticlesinpreventingexperimentalpostoperativeperitonealadhesionsinvivoandnbspinvitro AT may efficacyandmechanismoftanshinoneiialiquidnanoparticlesinpreventingexperimentalpostoperativeperitonealadhesionsinvivoandnbspinvitro AT lix efficacyandmechanismoftanshinoneiialiquidnanoparticlesinpreventingexperimentalpostoperativeperitonealadhesionsinvivoandnbspinvitro AT wangx efficacyandmechanismoftanshinoneiialiquidnanoparticlesinpreventingexperimentalpostoperativeperitonealadhesionsinvivoandnbspinvitro AT weiy efficacyandmechanismoftanshinoneiialiquidnanoparticlesinpreventingexperimentalpostoperativeperitonealadhesionsinvivoandnbspinvitro AT houc efficacyandmechanismoftanshinoneiialiquidnanoparticlesinpreventingexperimentalpostoperativeperitonealadhesionsinvivoandnbspinvitro AT lins efficacyandmechanismoftanshinoneiialiquidnanoparticlesinpreventingexperimentalpostoperativeperitonealadhesionsinvivoandnbspinvitro AT houl efficacyandmechanismoftanshinoneiialiquidnanoparticlesinpreventingexperimentalpostoperativeperitonealadhesionsinvivoandnbspinvitro AT wangc efficacyandmechanismoftanshinoneiialiquidnanoparticlesinpreventingexperimentalpostoperativeperitonealadhesionsinvivoandnbspinvitro |
| _version_ |
1718403576112349184 |